Recent studies have shown that CD33+CD11b+HLA-DR–/lo cells from cancer patients have a complete overlap with monocytic-MDSCs and PMN-MDSCs (Supplementary Fig. S9c), which were often defined as cells co-expressing CD14 and CD1537,38. The gene discussed is CD33; the disease is cancer.